AbbVie (ABBV)

AI-powered earnings call analysis for AbbVie. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

AbbVie earnings call scheduled for Jul 30, 2026 (before market open)

New episode expected Jul 31, 2026

Latest Episode

Q1 2026 Earnings

6:41 • 4/29/2026

AbbVie (ABBV) - Q1 2026

0:00

6:41

Speed:

Q1 2026 Earnings

9:23 • 2026/4/29

AbbVie (ABBV) - Q1 2026

0:00

9:23

Speed:

Q1 2026 Earnings

10:17 • 29/04/2026

AbbVie (ABBV) - Q1 2026

0:00

10:17

Speed:

Q1 2026 Earnings

9:31 • 29/4/2026

AbbVie (ABBV) - Q1 2026

0:00

9:31

Speed:

Q1 2026 Earnings

8:28 • 29.4.2026

AbbVie (ABBV) - Q1 2026

0:00

8:28

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q1 2026 Earnings

6:41

AbbVie delivered strong Q1 2026 results with $15.0B revenue (+12.4%) and $2.65 adjusted EPS, raising full-year guidance to $14.08-$14.28 on robust immunology and neuroscience momentum, while advancing transformational pipeline programs including Skyrizi combinations and obesity therapeutics.